Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Goblet Cell Secretion
- Molecular classification
- Cellular Process, Physiological Process
01
Overview
Goblet cell secretion is a vital physiological process involving the synthesis and regulated exocytosis of mucins by goblet cells. This secretion forms a protective mucus barrier on epithelial surfaces, particularly in the intestines and respiratory tract. Dysregulation of this process is implicated in various diseases, including asthma, IBD, and cystic fibrosis. The process is influenced by a variety of stimuli (irritants, pathogens and cytokines), and can be therapeutically modulated to address disease pathologies.
- Other names
- Mucus secretion by goblet cellsMucin secretionGoblet cell exocytosis
02
Mechanism of action
Varied, depending on the drug. Mucolytics break down mucus; corticosteroids reduce inflammation; bronchodilators improve airway function; CFTR modulators correct defects in chloride transport in cystic fibrosis.
03
Biological functions
Mucus productionBarrier formationLubrication of epithelial surfacesProtection against pathogensImmunoregulation (indirectly)Mucociliary clearance
04
Disease associations
Asthma (hypersecretion)Chronic Obstructive Pulmonary Disease (COPD) (hypersecretion)Inflammatory Bowel Disease (IBD) (deficient secretion)Cystic Fibrosis (altered mucus composition)Infections (impaired barrier function)Allergic reactions
05
Safety considerations
Excessive mucolysis can impair barrier functionCorticosteroid side effects (long-term use)Mucus plugging if mucociliary clearance is impairedDrug interactionsDevelopment of resistance to anti-inflammatory drugs
06
Interacting drugs
Mucolytics (e.g., N-acetylcysteine, guaifenesin)
4 more in the full profile.
07
Biomarkers
Mucin levels in sputum/bronchoalveolar lavage (BAL)Goblet cell number in biopsiesExpression levels of MUC2, MUC5AC, MUC5BInflammatory cytokines (e.g., IL-13, IL-4) correlated with goblet cell hyperplasia
Beyond the preview
Go deeper on Goblet Cell Secretion.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Goblet Cell Secretion.